Three months ended 31 March 2008Â
*Â Local currency sales increased by 26.5% and Euro sales increased
by 20.7%, to ¤324.2m (¤268.5m).
*Â Average size of the sales force increased by 25%, to 2,610,600
consultants and closing sales force was up by 24%.
* EBITDA increased by 23%, to ¤57.2m (¤46.4m).
*Â Operating margin before restructuring costs, due to the new
operational platform, was 15.5% (15.4%) resulting in a 22%
increase in operating profit to ¤50.2m (¤41.3m).
* Net profit before restructuring costs increased by 22% to ¤37.9m
(¤31.1m).
*Â EPS after dilution and before restructuring costs increased by
22% to ¤0.67 (¤0.55). Diluted EPS after restructuring costs
amounted to ¤0.58 (¤0.55).
* Cash flow from operating activities amounted to ¤3.3m (¤30.4)
partly due to the cash impact for the restructuring programme and
an inventory build up.
*Â The new operational platform is now fully up and running.
Â
The full report including tables can be downloaded from the following
link:
Â
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.